| 000 | 01746 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513202929.0 | ||
| 264 | 0 | _c20000322 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.2000.2213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWächtershäuser, A | |
| 245 | 0 | 0 |
_aExpression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cFeb 2000 |
||
| 300 |
_a778-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a5-Lipoxygenase-Activating Proteins |
| 650 | 0 | 4 |
_aArachidonate 5-Lipoxygenase _xgenetics |
| 650 | 0 | 4 |
_aButyric Acid _xpharmacology |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyeicosatetraenoic Acids _xmetabolism |
| 650 | 0 | 4 |
_aLipoxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aSteinhilber, D | |
| 700 | 1 | _aLoitsch, S M | |
| 700 | 1 | _aStein, J | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 268 _gno. 3 _gp. 778-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2000.2213 _zAvailable from publisher's website |
| 999 |
_c10633597 _d10633597 |
||